Enron-related regulatory issues hit derivatives industry

Many US politicians are looking to use the Enron scandal to score political points or push pet issues through Congress. Some of these initiatives seek to increase government oversight of the listed and over-the-counter derivatives markets. But the legislative calendar is crammed with higher priority issues such as the budget, appropriations bills and campaign finance reform, so the Enron-related measures face an uncertain future.

The Enron issues with the strongest chances of action are indi

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: